Navidea Biopharmaceuticals Stock Net Income
| NAVBDelisted Stock | USD 0.0001 0.00 0.00% |
As of the 2nd of March, Navidea Biopharmaceutica secures the Risk Adjusted Performance of 0.0921, mean deviation of 14.81, and Standard Deviation of 52.16. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Navidea Biopharmaceutica, as well as the relationship between them.
Navidea Biopharmaceutica's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Navidea Biopharmaceutica's valuation are provided below:Navidea Biopharmaceuticals does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Navidea |
Search Suggestions
| NA | Nano Labs | ETF |
| NAK | Northern Dynasty Minerals | Company |
| NAD | Nuveen Dividend Advantage | Fund |
| NAS | NAS | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Navidea Biopharmaceuticals reported net income of (15.18 Million). This is 104.45% lower than that of the Biotechnology sector and 121.67% lower than that of the Health Care industry. The net income for all United States stocks is 102.66% higher than that of the company.
Navidea Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Navidea Biopharmaceutica's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Navidea Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Navidea Biopharmaceutica by comparing valuation metrics of similar companies.Navidea Biopharmaceutica is currently under evaluation in net income category among its peers.
Navidea Fundamentals
| Return On Equity | -11.0 | |||
| Return On Asset | -1.22 | |||
| Current Valuation | 3.5 M | |||
| Shares Outstanding | 100.08 M | |||
| Shares Owned By Insiders | 35.43 % | |||
| Shares Owned By Institutions | 1.50 % | |||
| Number Of Shares Shorted | 2.69 M | |||
| Price To Earning | 0.53 X | |||
| Price To Book | 8.16 X | |||
| Price To Sales | 84.14 X | |||
| Revenue | 65.65 K | |||
| Gross Profit | (119.3 K) | |||
| EBITDA | (14.05 M) | |||
| Net Income | (15.18 M) | |||
| Cash And Equivalents | 328.01 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 2.43 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 0.22 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (8.99 M) | |||
| Short Ratio | 0.52 X | |||
| Earnings Per Share | (0.39) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 11 | |||
| Beta | 1.5 | |||
| Market Capitalization | 8.04 M | |||
| Total Asset | 4.37 M | |||
| Retained Earnings | (388 M) | |||
| Working Capital | (6.74 M) | |||
| Current Asset | 12.58 M | |||
| Current Liabilities | 6.18 M | |||
| Net Asset | 4.37 M |
About Navidea Biopharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Navidea Biopharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Navidea Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Navidea Biopharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Navidea Pink Sheet
If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |